Distinct patterns of brain inflammation identified through PET imaging may explain disease progression and severity in ...

Pratap Chand, MD, DM, FRCP, University of Louisville School of Medicine, Division of Movement Disorders, Frazier Rehab Neuroscience Institute, 220 Abraham Flexner Way, Ste 1503 Louisville, KY ...

Pratap Chand, MD, DM, FRCP, University of Louisville School of Medicine, Division of Movement Disorders, Frazier Rehab Neuroscience Institute, 220 Abraham Flexner Way, Ste 1503 Louisville, KY ...

A novel PET imaging study has identified unique patterns of neuroinflammation in patients with progressive apraxia of speech ...

A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of ...

A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of ...

Assessing α-synuclein SAA kinetic measures might aid in the diagnostic differentiation of Parkinson's disease from progressive supranuclear palsy with Lewy body co-pathology. Furthermore, faster ...

For the first time, we show that differences in the aggressiveness of α-synuclein seeding can help distinguish Parkinson’s disease from similar conditions like progressive supranuclear palsy where ...

Early diagnosis of Alzheimer’s disease and its prodromal stage, also known as mild cognitive impairment (MCI), is critical since some patients with progressive MCI will develop the disease. We propose ...

Coughlin DG, Litvan I. Progressive supranuclear palsy: Advances in diagnosis and management. Parkinsonism Relat Disord. 2020 Apr;73:105-116. doi: 10.1016/j.parkreldis.2020.04.014.

Ferrer, a B Corp-certified international pharmaceutical company, has announced that FNP-223, a novel therapy in-licensed from Asceneuron and aimed at slowing the development of progressive ...